CIPCA

CIPCA: The Psychological Vaccination for Children in Crisis

A scientifically developed, cost-effective intervention to prevent post-traumatic psychopathology and radicalization.

Strategic Overview

The Crisis Intervention Program for Children and Adolescents (CIPCA) is a scientifically developed protocol designed to fill the critical gap between immediate disaster relief and long-term psychiatric treatment. Operating on a Bio-Psycho-Social model, CIPCA functions as a "psychological vaccination," aiming to prevent the onset of disorders before they become chronic.

Systemic Prevention

Unlike traditional therapies that treat established disorders, CIPCA provides early intervention to prevent negative information processing, reducing the risk of PTSD and anti-social behavior.

Operational Scalability

Designed for high-volume crisis scenarios, the program utilizes a "Training of Trainers" (ToT) model, allowing rapid capacity building among local professionals.

Cost-Efficiency

By delivering intervention in a single, one-hour session (individual or group) and utilizing early screening, CIPCA significantly reduces the long-term societal costs associated with untreated mental health issues.

Methodology & Implementation

CIPCA offers a structured framework that integrates intervention with data collection, making it suitable for both clinical application and longitudinal research.

The Intervention Protocol

A single 60-minute session led by two certified leaders (mixed gender) guiding children through the Crisis Expression Guidelines (CEG)—a Socratic method to restructure negative thoughts into positive coping strategies.

Built-in Screening

The intervention includes the Crisis Screening Instrument (CSI), enabling immediate identification and referral of high-risk cases to specialized psychiatric care.

Standardized Training

Implementation is supported by a 30-hour, ECTS-accredited certification course for leaders, ensuring quality control and consistency across deployments.

Evidence & Impact

Developed at Metin Health House in collaboration with Uppsala University Innovation (UUI) and supported by the World Health Organization (WHO), CIPCA has been rigorously field-tested.

Articles & Research